VREOF — Vireo Growth Inc.
—
OTC ·
Health Care ·
Pharmaceuticals ·
CIK 1771706 ·
Last close
$9.44
Market Cap
$464.29M
52W High
$14.85
52W Low
$8.91
ADV30
13,517
Next earnings
2026-08-12
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | GrossProfit | OpIncome | NetIncome | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Mar 2026 | 106,200,000 | 59,300,000 | 17,700,000 | -20,300,000 | 928,800,000 | 122,400,000 | 634,700,000 |
| Dec 2025 | 104,510,462 | 56,882,219 | 2,615,971 | -20,372,228 | 817,154,292 | 102,229,759 | 509,729,300 |
| Sep 2025 | 91,655,155 | 37,382,999 | 1,612,680 | -26,298,861 | 678,918,509 | 97,151,669 | 432,612,987 |
| Jun 2025 | 48,063,010 | 20,417,847 | 2,710,753 | -14,934,029 | 659,340,259 | 99,134,913 | 390,761,769 |
Cashflow TTM (yfinance, fills SEC gap)
Operating CF
$19,011,491
Investing CF
$17,859,451
Financing CF
$14,719,059
CapEx
$-40,016,673
Dividends Paid
—
Buybacks
—
EPS Diluted TTM
$-0.10
As of
2026-06-07
Balance + Analyst (yfinance extras)
Retained Earnings
$-319,900,000
Inventory
$76,100,000
Receivables
$35,700,000
ST Investments
$1,000,000
EBIT TTM
$-8,822,270
Pretax Income TTM
$-39,277,118
Interest Exp TTM
$30,454,848
Analysts
1
Yahoo Snapshot (yfinance, live)
Total Revenue
$350,469,280
EBITDA
$45,245,040
Free Cash Flow
$66,416,544
Enterprise Value
$715,745,536
Total Cash
$123,400,000
Total Debt
$403,700,000
Shares Out
49,182,773
Trailing EPS
$-2.70
Book Value
$8.17
ROE
-47.5%
ROA
2.6%
Div Yield
—
Annual Trend (SEC EDGAR, last 4y)
Revenues vs Net Income (last 4y)
| FY end | Revenues | OpIncome | NetIncome | Assets | Liabilities | Equity | OCF |
|---|---|---|---|---|---|---|---|
| Dec 2025 | 268,769,268 | 10,159,790 | -68,113,908 | 817,154,292 | 509,729,300 | — | 3,711,491 |
| Dec 2024 | 99,384,221 | 18,067,365 | -28,007,509 | 278,862,918 | 223,299,395 | — | -10,234,550 |
| Dec 2023 | 88,133,163 | 10,579,778 | -25,547,089 | 183,263,719 | 199,307,368 | — | -965,906 |
| Dec 2022 | 74,625,867 | -6,939,365 | -42,457,444 | 159,156,403 | 155,715,519 | — | -18,073,265 |
TTM Snapshot
Revenues TTM
—
NetIncome TTM
—
OpCashFlow TTM
—
Assets (Latest)
—
Forward EPS
$1.53
Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| AQST | Aquestive Therapeutics, Inc. | $463.60M | $3.69 | — |
| QTTB | Q32 Bio Inc. | $465.83M | $15.68 | — |
| RZLT | Rezolute, Inc. | $454.50M | $4.72 | — |
| HELP | CYBIN INC. | $484.72M | $7.82 | — |
| SLN | Silence Therapeutics plc | $495.49M | $10.49 | — |
News headlines (Yahoo Finance, 1h cache)
Vireo Growth Inc. Announces a Four-Deal Transaction to Establish Presence in Ohio
2026-07-31 10:45 · Yahoo
FLUENT Announces Shareholder Approval of All-Stock Transaction with Vireo Growth
2026-07-29 03:48 · Yahoo
Vireo Growth to Buy Planet 13 Holdings in All-Stock Deal
2026-07-27 17:48 · Yahoo
Vireo Growth Inc. to Acquire Planet 13 Holdings Inc.
2026-07-27 10:45 · Yahoo
Fluent Announces Receipt of Exemptive Relief Relating to Annual General and Special Meeting; Extension of Proxy Deposit Deadline
2026-07-23 22:58 · Yahoo
FLUENT Announces Definitive Agreement to Sell New York License and Certain Operations
2026-07-23 11:30 · Yahoo
Vireo Growth Will Acquire up to $35 Million in Assets From Cannabist
2026-07-20 18:20 · Yahoo
Vireo Growth Inc. to Acquire Certain Assets of The Cannabist Company Holdings Inc.
2026-07-20 10:45 · Yahoo
Vireo Growth Inc. Completes Acquisition of Pennsylvania Dispensary License Transaction
2026-07-18 00:27 · Yahoo
FLUENT Provides Update and Supplemental Disclosure on Circular to Approve All-Stock Transaction With Vireo Growth Inc.
2026-07-17 22:17 · Yahoo
Recent Insider Activity
No insider activity indexed for this ticker.